Liquid biopsy identifies mutations in colorectal cancer undetected in tissue biopsy

14 julio 2015

The CORRECT study is one of the largest trials to date comparing data provided by liquid versus tissue biopsy in metastatic colorectal cancer patients. According to the study, liquid biopsy (BEAMing technology) could become an essential tool for analyzing tumor genotypes in real time, and identifying significant mutations that occur during the course of disease and are not detected by tissue biopsy.img src=»» height=»1″ width=»1″ alt=»»/